A distinctive effect from the phase 3 data is dysesthesia, a skin-sensation symptom described as tingling or sensitivity, more common at higher doses
Available from: Nauck MA, Quast DR, Wefers J, Meier JJ (2021) GLP-1 receptor agonists in the treatment of type 2 diabetes state-of-the-art
The main effect of endogenous GIP regarding weight is primarily on adipose tissue, where it promotes positive energy balance
Mostly in lab studies looking at cellular health, tissue regeneration, and oxidative stress reduction
Let me do the math real quick
Glatter: Another important option that deserves earlier considerationnot later referralis metabolic and bariatric surgery